NLM Logo

farletuzumab MeSH Supplementary Concept Data 2022


MeSH Supplementary
farletuzumab
Unique ID
C527484
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C527484
Entry Term(s)
MORAb-003
Pharm Action
Antineoplastic Agents
Registry Number
2O09BG0OWA
Previous Indexing
*ANTIBODIES, MONOCLONAL (2008-2011)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
31
Note
a fully humanized MAb that recognizes folate receptor alpha; may be useful in treating ovarian cancer; in phase II clinical trials
Source
Curr Opin Investig Drugs 2007 Dec;8(12):1067-73
Date of Entry
2008/03/21
Revision Date
2019/10/31
farletuzumab Preferred
MORAb-003 Narrower
page delivered in 0.004s